Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines. - Wikidata - wikimedia - TriplyDB

Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.

Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.

http://www.wikidata.org/entity/Q41395304

about

Current controversies in the diagnosis and management of von Willebrand disease Compound heterozygous hemophilia A in a female patient and the identification of a novel missense mutation, p.Met1093Ile Alternate considerations for current concepts in ITP.Misfolding of vWF to pathologically disordered conformations impacts the severity of von Willebrand disease Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy.Historical perspective and future directions in platelet research.Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease.A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation.Treatment of the acquired von Willebrand syndrome.Von Willebrand disease in the emergency department.Hypertrophic obstructive cardiomyopathy, acquired von Willebrand syndrome, and gastrointestinal bleeding.Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease.Response to low-dose desmopressin by a subcutaneous route in children with type 1 von Willebrand disease.The isolated prolonged PTT.Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study.Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease.Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies.Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.A comparative evaluation of a new automated assay for von Willebrand factor activity.Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome.Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.Prevalence of Bleeding Symptoms among Adolescents and Young Adults in the Capital City of Saudi Arabia.von Willebrand disease.Von Willebrand disease in the elderly: clinical perspectives

P2860

Q26796446-34E94896-1915-49B7-B26D-91F70E2149A7 Q28660473-1D4B2DF9-7E22-41BE-9383-36CD14EE2E74 Q33407813-79BA0A3C-4C33-4FBF-96E1-FE7EC7CB7695 Q33417479-292CCD31-B178-4D86-B518-1F43F9245349 Q34492729-871F1AB0-CA8F-4400-9006-B86ADAAA014C Q34616043-FE96B3D2-33E8-4101-BBD7-CDB9A0879AB0 Q35185593-B9C61623-DB2B-41C4-8AE2-15401733FE02 Q36417720-2E42A2B2-03F8-4321-92AE-3C2EDAE11295 Q36925057-7F547B29-C4B1-4E35-BBC8-80935D5A060F Q38636087-7BD32603-A48F-4ACD-A89D-3F860E31C1B0 Q40329972-A0D8F064-1E3A-4661-A760-607B095C40F3 Q42642393-F75E2977-47F1-4F9C-9382-4A52605234E0 Q42822767-6D35F3BE-7192-4F09-A644-AF2FE3CB1195 Q44083412-B177849E-8871-45E1-86D3-52110E879255 Q45004118-1EAEECAF-A976-4C9F-9276-5C902BD63445 Q45857162-6F6D8502-923C-474E-BF55-62D8157BE606 Q45862976-2852C8E1-314F-4F46-AF72-89B3FCED3D87 Q45867275-5244A6AF-DC56-45DD-B8FA-269DCC16F5A8 Q45867954-40CC45C3-65A0-4F97-9176-CECBE15AAFF0 Q45883482-816045D6-767C-4EAF-86B4-18F2745F59B7 Q45887986-61A7B670-EBA4-4DA5-845B-14093ABE0531 Q45970222-FB8B2F05-6009-41E7-B2EA-1E040C75317E Q49130346-A173F67C-B8F2-4549-A0AA-80A298354F91 Q55034996-02AFA440-DE61-44C1-AE2C-687D30062A35 Q55053921-D6B89219-798D-4ED5-BCCE-D05653FCEF22 Q58781583-457693C2-E5D5-4634-BA96-9D9989782889

P2860

Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.

http://www.wikidata.org/entity/Q41395304

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Clinical and laboratory diagno ...... the 2008 NHLBI/NIH guidelines.

@en

type

label

Clinical and laboratory diagno ...... the 2008 NHLBI/NIH guidelines.

@en

prefLabel

Clinical and laboratory diagno ...... the 2008 NHLBI/NIH guidelines.

@en

P1433

Q41395304-B8777418-2B60-49F6-BBB1-855B69223FDA

P1476

Q41395304-0AB6DD59-CFFE-4BFB-A806-0631601F368C

P2093

Q41395304-0937DBA8-D6D2-4ED2-B4E5-F859091F230A

Q41395304-0B1963DD-FE81-4233-86AD-F14F9DC8211D

Q41395304-405AD48F-3009-41FB-AA9D-240664923421

Q41395304-40C11A86-61F8-4EAA-AE50-B22292DB3282

Q41395304-5E54E198-1D6D-4D06-9EEB-382D94F249E2

Q41395304-63B7D211-C77B-47CF-8E5F-F468A2A4BEE3

Q41395304-6FAD438A-6E0D-40C9-83A9-7FD924D24617

Q41395304-7B2B9E44-A8A3-4B82-BAC1-5A5011BA0BA9

Q41395304-8E43AC8B-363E-41F3-BD48-1DF33DA3ED5F

Q41395304-9BD7707F-9728-4EF7-82FB-3D13116FA386

P2860

Q41395304-3007A6F5-DEE3-45D1-954C-247320B85091

Q41395304-5175468D-5789-4A38-AE03-E174FA3897C0

Q41395304-59071422-EBEA-4C06-B5F1-BE51073D345A

Q41395304-8B0C9943-8F5F-4F22-89F3-A302530C6147

Q41395304-927F228E-A60D-4BF9-8CB9-EBBABE8CDC8F

Q41395304-A46F5F98-7BB2-4C04-8777-0A9C4A7131F7

P304

Q41395304-A3A6944F-3A0E-4F83-87BC-8780661CB5F6

P31

Q41395304-79F9D1C1-4A88-4561-9759-81F18B486795

P356

Q41395304-74E319B1-DB53-4558-9164-AD21BE266806

P433

Q41395304-2A1F53D4-E8DC-445D-979A-E046F60442BE

P478

Q41395304-0C835672-1BA0-497D-949B-FE9CD78EF9EB

P577

Q41395304-06025042-14EA-454D-9209-3E2A64719564

P5875

Q41395304-8A51A5E8-A837-406C-B943-1FA0CA8BC779

P698

Q41395304-ACB36DEE-0D84-4F99-83A5-8256DBD88A67

P932

Q41395304-C9FDE2D0-17A4-4A15-A384-A091AA497DCA

P356

P1433

American Journal of Hematology

P1476

Clinical and laboratory diagno ...... the 2008 NHLBI/NIH guidelines.

@en

P2093

Andra H James

http://www.w3.org/2001/XMLSchema#string

Barbara P Yawn

http://www.w3.org/2001/XMLSchema#string

J Evan Sadler

http://www.w3.org/2001/XMLSchema#string

Mae B Hultin

http://www.w3.org/2001/XMLSchema#string

Margaret E Rick

http://www.w3.org/2001/XMLSchema#string

Marilyn J Manco-Johnson

http://www.w3.org/2001/XMLSchema#string

Mark Weinstein

http://www.w3.org/2001/XMLSchema#string

Robert R Montgomery

http://www.w3.org/2001/XMLSchema#string

Thomas L Ortel

http://www.w3.org/2001/XMLSchema#string

William L Nichols

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study.

Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.

Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology.

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.

P304

366-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.21405

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24401974

http://www.w3.org/2001/XMLSchema#string

P698

19415721

http://www.w3.org/2001/XMLSchema#string

P932

5592788

http://www.w3.org/2001/XMLSchema#string